How Ebola and Marburg viruses battle the immune system
- PMID: 17589545
- DOI: 10.1038/nri2098
How Ebola and Marburg viruses battle the immune system
Abstract
The filoviruses Ebola and Marburg have emerged in the past decade from relative obscurity to serve now as archetypes for some of the more intriguing and daunting challenges posed by such agents. Public imagination is captured by deadly outbreaks of these viruses and reinforced by the specter of bioterrorism. As research on these agents has accelerated, it has been found increasingly that filoviruses use a combination of familiar and apparently new ways to baffle and battle the immune system. Filoviruses have provided thereby a new lens through which to examine the immune system itself.
Similar articles
-
Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.Nat Med. 2005 Jul;11(7):786-90. doi: 10.1038/nm1258. Epub 2005 Jun 5. Nat Med. 2005. PMID: 15937495
-
A single shot against Ebola and Marburg virus.Nat Med. 2005 Jul;11(7):720-1. doi: 10.1038/nm0705-720. Nat Med. 2005. PMID: 16015361 No abstract available.
-
Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection.Vaccine. 2004 Sep 3;22(25-26):3495-502. doi: 10.1016/j.vaccine.2004.01.063. Vaccine. 2004. PMID: 15308377
-
Progress in recombinant DNA-derived vaccines for Lassa virus and filoviruses.Virus Res. 2011 Dec;162(1-2):148-61. doi: 10.1016/j.virusres.2011.09.005. Epub 2011 Sep 10. Virus Res. 2011. PMID: 21925552 Review.
-
DNA vaccines for biodefense.Expert Rev Vaccines. 2009 Dec;8(12):1739-54. doi: 10.1586/erv.09.132. Expert Rev Vaccines. 2009. PMID: 19943766 Review.
Cited by
-
Point/counterpoint. Radiotherapy is an appropriate treatment to consider for patients infected with the Ebola virus.Med Phys. 2015 Mar;42(3):1149-52. doi: 10.1118/1.4903900. Med Phys. 2015. PMID: 25735269 Free PMC article. No abstract available.
-
Profiling the native specific human humoral immune response to Sudan Ebola virus strain Gulu by chemiluminescence enzyme-linked immunosorbent assay.Clin Vaccine Immunol. 2012 Nov;19(11):1844-52. doi: 10.1128/CVI.00363-12. Epub 2012 Sep 19. Clin Vaccine Immunol. 2012. PMID: 22993411 Free PMC article.
-
dsRNA binding characterization of full length recombinant wild type and mutants Zaire ebolavirus VP35.Antiviral Res. 2012 Mar;93(3):354-63. doi: 10.1016/j.antiviral.2012.01.005. Epub 2012 Jan 25. Antiviral Res. 2012. PMID: 22289166 Free PMC article.
-
Ebola virus disease in nonendemic countries.J Formos Med Assoc. 2015 May;114(5):384-98. doi: 10.1016/j.jfma.2015.01.012. Epub 2015 Apr 13. J Formos Med Assoc. 2015. PMID: 25882189 Free PMC article. Review.
-
Viral manipulation of cellular protein conjugation pathways: The SUMO lesson.World J Virol. 2013 May 12;2(2):79-90. doi: 10.5501/wjv.v2.i2.79. World J Virol. 2013. PMID: 24175232 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous